Perez EA - Search Results

1

Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.

Perez EA, Geoffroy FJ, Hillman S, Johnson EA, Farr GH Jr, Tazelarr HD, Hatfield AK, Krook JE, Maillard JA, Levitt R, Marks RS. Perez EA, et al. Lung Cancer. 2004 Jun;44(3):347-53. doi: 10.1016/j.lungcan.2003.12.002. Lung Cancer. 2004. PMID: 15140548 Clinical Trial.

2

Adjuvant therapy approaches to breast cancer: should taxanes be incorporated?

Perez EA. Perez EA. Curr Oncol Rep. 2003 Jan;5(1):66-71. doi: 10.1007/s11912-003-0089-4. Curr Oncol Rep. 2003. PMID: 12493153 Review.

3

Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study.

Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Jatoi A, et al. Among authors: perez ea. Am J Clin Oncol. 2003 Oct;26(5):441-7. doi: 10.1097/01.coc.0000027460.53907.38. Am J Clin Oncol. 2003. PMID: 14528068 Clinical Trial.

4

Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.

Perez EA. Perez EA. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S113-6. doi: 10.3816/cbc.2004.s.004. Clin Breast Cancer. 2004. PMID: 14754468 Review.

5

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

Perez EA, Hillman DW, Mailliard JA, Ingle JN, Ryan JM, Fitch TR, Rowland KM, Kardinal CG, Krook JE, Kugler JW, Dakhil SR. Perez EA, et al. J Clin Oncol. 2004 Jul 15;22(14):2849-55. doi: 10.1200/JCO.2004.10.047. J Clin Oncol. 2004. PMID: 15254052 Clinical Trial.

6

Carboplatin in combination therapy for metastatic breast cancer.

Perez EA. Perez EA. Oncologist. 2004;9(5):518-27. doi: 10.1634/theoncologist.9-5-518. Oncologist. 2004. PMID: 15477636 Free article. Review.

7

Anthracycline vs nonanthracycline adjuvant therapy for breast cancer.

Tack DK, Palmieri FM, Perez EA. Tack DK, et al. Among authors: perez ea. Oncology (Williston Park). 2004 Oct;18(11):1367-76; discussion 1378, 1381. Oncology (Williston Park). 2004. PMID: 15609467 Free article. Review.

8

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.

Burch PA, Mailliard JA, Hillman DW, Perez EA, Krook JE, Rowland KM, Veeder MH, Cannon MW, Ingle JN. Burch PA, et al. Among authors: perez ea. Am J Clin Oncol. 2005 Apr;28(2):195-200. doi: 10.1097/01.coc.0000144815.54746.d0. Am J Clin Oncol. 2005. PMID: 15803016 Clinical Trial.

9

Phase II trial of dolastatin-10 in patients with advanced breast cancer.

Perez EA, Hillman DW, Fishkin PA, Krook JE, Tan WW, Kuriakose PA, Alberts SR, Dakhil SR. Perez EA, et al. Invest New Drugs. 2005 Jun;23(3):257-61. doi: 10.1007/s10637-005-6735-y. Invest New Drugs. 2005. PMID: 15868383 Clinical Trial.

10

A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.

Perez EA, Suman VJ, Fitch TR, Mailliard JA, Ingle JN, Cole JT, Veeder MH, Flynn PJ, Walsh DJ, Addo FK. Perez EA, et al. Oncology. 2005;69(2):117-21. doi: 10.1159/000087813. Epub 2005 Aug 23. Oncology. 2005. PMID: 16118507 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters